SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma Sciences informs about resignation of directors

05 Aug 2023 Evaluate

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III to the said Regulations, Solara Active Pharma Sciences has informed that following directors have resigned from the directorship of the company with effect from August 5, 2023: Aditya Puri (DIN: 00062650) has resigned from the position of Chairman and Non-Executive Director of the Company due to personal reasons and Vineeta Rai (DIN: 07013113) has resigned from the position of Non- Executive Independent Director of the Company due to personal reasons. Further, it has confirmed that there are no material reasons other than the reasons specified in the resignation letter received from Vineeta Rai enclosed as Annexure I, confirming that there are no material reasons other than the reasons mentioned in the resignation letter. Disclosures required pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Regulations and SEBI Circular CIR/CFD/CMD/ 4/2015 dated 09th September 2015 is enclosed as Annexure - II. The company has informed that Aditya Puri who has served as the Non-Executive Director & Chairman of the company for a period of 2 years (since August 4, 2021) has decided to pursue his personal interest and consequently has decided to resign from the Board of Solara.

The above information is a part of company’s filings submitted to BSE.


Solara Active Pharma Share Price

489.30 -4.40 (-0.89%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×